AP
The startup develops therapeutics that modulate the activity of specific protein targets associated with cancer and other diseases. By enhancing treatment efficacy and minimizing toxicity, their therapies aim to improve patient outcomes in oncology.
Updated 18 months ago
Funding
$600K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
ST
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops therapeutics that modulate the activity of specific protein targets associated with cancer and other diseases. By enhancing treatment efficacy and minimizing toxicity, their therapies aim to improve patient outcomes in oncology.